Skip to main content

Endoscopic endonasal transsphenoidal approach improves endocrine function and surgical outcome in primary craniopharyngioma resection: a systematic review and meta-analysis

Abstract

Background

Craniopharyngiomas (CPs) are generally derived from the craniopharyngeal duct epithelium, accounting for 38% and 24.5% of mortality in pediatric and adult patients, respectively. At present, the widespread application of the endoscopic endonasal transsphenoidal approach (EEA) has led to controversy between the traditional microscopic transcranial approach (TCA) and EEA in relation to the surgical management of CPs.

Object and method

We performed a systematic review and meta-analysis comparing the complications, surgical outcomes, and endocrine functions of patients with CPs to provide evidence-based decision-making in their surgical management.

Result

Overall, 11 observational studies with 12,212 participants were included in the meta-analysis, in which five of them only included an adult population, three of them only included a child population, and the other three studies included a mixed population (adult and child). In pediatric patients, the EEA achieved a higher gross total resection (GTR) rate (odds ratio (OR) = 5.25, 95%CI: 1.21–22.74), lower recurrence rate (OR = 0.54, 95%CI: 0.31–0.94, p = 0.030), and less hypopituitarism (OR = 0.34, 95%CI: 0.12–0.97, p = 0.043). In adult patients, EEA significantly improved mortality (OR = 0.09, 95%CI: 0.06–0.15, p < 0.001) and visual outcomes (visual improvement: OR = 3.42, 95%CI: 1.24–9.40, p = 0.017; visual deficit: OR = 0.30, 95%CI: 0.26–0.35) with decreases in postoperative stroke (OR = 0.58, 95%CI: 0.51–0.66, p < 0.001), hydrocephalus, and infections (OR = 0.32, 95%CI: 0.24–0.42, p < 0.001).

Conclusion

Compared with the traditional TCA in primary CP resection, the development and wide application of EEA optimistically decreased the recurrence rate of CP, alleviated hypopituitarism with improvement in the GTR rate of pediatric patients, and significantly improved the visual outcomes, hydrocephalus, postoperative stroke, survival, and infection rates of the patients. Therefore, EEA is an optimal approach for primary CP resection.

Introduction

Craniopharyngiomas (CPs) constitute 1.2–4.6% of all intracranial tumors, accounting for 0.5–2.5 new cases per 1 million population per year globally [1]. As a slow-growing benign tumor of the central nervous system, CPs generally originate from the hypothalamic-pituitary axis and develop from Rathke’s pouch [2, 3]. Approximately 50% of CPs can be found along the hypothalamic-pituitary axis and tuber cinereum at the level of the bottom of the third ventricle and develop primarily toward the third ventricle, which brings CPs to the possibility of being surrounded by several vital structures, such as hypothalamus, optic chiasm, and pituitary gland [1, 2, 4]. Therefore, the surgical management of CPs still remains a great challenge in clinical practice [2, 5].

Although surgical resection is considered the primary treatment for CPs, the most optimal surgical treatment approach has not been fully established. Generally, CPs are commonly excised via traditional microscopic TCA. Recently, the application of EEA in tumors, which are resected through a transsphenoidal procedure, has become more important. Over the past decades, with the advancement of neurosurgery instruments, the EEA has gradually surpassed traditional microscopic TCA for the surgical management of CPs [6, 7]. This prior effect may be attributed to the fact that the EEA provides significant improvement in the GTR rate and postoperative hypopituitarism, providing a more direct visualization of these tumors [8, 9]. Although several evidences support that the EEA increased the cerebrospinal fluid (CSF) leakage rate, less occurrence was observed in the visual deterioration, diabetes insipidus, tumor recurrence, and recurrence-free survival rate. However, in consideration of the complexity of this condition, some literatures identified distinct conclusions, including a similar GTR rate and equal recurrence rate between the EEA and TCA. Therefore, further research is needed to confirm the safety and acceptability of the EEA in this disputable field [10].

At present, only a few meta-analyses comparing the EEA and TCA were published, which were limited to mixing adults and pediatric patients or synthesizing effect size of single proportions rather than dichotomous outcomes [8, 11,12,13,14,15,16]. It is well-accepted that there is a limitation of the methodology of statistical analysis in single-proportion meta-analysis, because a single-proportion meta-analysis commonly ignores the heterogeneity of the included study when pooling proportions and drawing conclusions, which might lead to a lack of interpretability and misleading conclusions [17,18,19]. Moreover, it is well-known that the clinical outcomes of the GTR rate, survival rate, pituitary hormone deficits, and incidence of hypothalamic-pituitary dysfunction disorders might be different between primary and repeat craniopharyngioma resection, whereas in these previous studies, the definition of the type of craniopharyngioma was not established (primary, recurrence or mixed) [20,21,22].

To summarize the above arguments, a large-scale comparative meta-analysis including current available studies might present better evidence in the field. In this study, we aim to provide the latest evidence by performing a systematic review and meta-analysis to quantificationally and comprehensively evaluate the safety and effectiveness of EEA and TCA in primary CP resection according to the stratification of different age groups (i.e., child, adult, and mixed populations).

Method

Data sources and search strategy

This study was conducted by following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines (PRISMA) [23], Assessing the methodological quality of systematic reviews Guidelines (AMSTAR) [24] and the Cochrane Collaboration’s systematic review framework. We performed a comprehensive search on PubMed, Ovid, and Cochrane Library databases to include potentially eligible studies. The search strategy was determined via the following items: (1) endoscopic endonasal; (2) (endoscopic endonasal) OR (endoscopic transsphenoidal) OR (transsphenoidal OR transcranial); (3) 1 OR 2; (4) craniopharyngioma; (5) (craniopharyngioma OR (Rathkes Pouch Tumor) OR (Rathke Pouch Tumor) OR (Rathkes Cleft Neoplasm) OR (Rathke Cleft Neoplasm) OR (Papillary Craniopharyngioma) OR (Child Craniopharyngioma) OR (Adamantinomatous Craniopharyngioma) OR (Adamantinomatous Craniopharyngiomas) OR (hypophyseal duct tumor) OR (adamantinoma) OR (adamantinomas) OR (Craniopharyngeal duct tumour) OR (Adamantinomatous tumour)); (6) 4 OR 5; (7) 3 AND 6.

Study identification and exclusion

The study comprising a detailed description of surgical outcomes for comparation between EEA and TCA in CPs patients was independently identified and reviewed by two experienced investigators. The third researcher would involve in the assessment, if the opposite judgment appears.

Inclusion criteria were as follows: (1) randomized controlled trials (RCTs) or observational studies investigating surgical outcomes of EEA as compared with TCA in CP resection; (2) patients were all diagnosed with primary CPs, not recurrently CPs; (3) postoperative outcomes were reported at least GTR and CSF leakage rate.

Exclusion criteria were as follows: (1) studies merely contained a single series; (2) populations included recurrent CPs; (3) surgical approaches were not EEA and TCA; (4) patients were treated with radiotherapy.

Data extraction

The following information was extracted: first author, journal name, year of publication, baseline demographic (mean age, gender proportion, and the number of participants in each group), and postoperative clinical characteristics: (1) surgical outcomes: GTR, recurrence, visual improvement and visual deficit; (2) endocrine functions: diabetes insipidus and hypopituitarism; (3) complications: CSF leakage, hydrocephalus, infection, stroke (ischemic and hemorrhagic), all-cause mortality, and thrombosis (pulmonary embolism or deep venous thrombosis); (4) length of stay (LOS) and follow-up period. No unpublished data were received by the authors from the included studies.

Two investigators independently collected these concerning medical data in eligible studies.

Quality assessment in individual studies

The methodological quality of included studies was independently evaluated by the consensus of two experienced investigators based on the Newcastle-Ottawa Scale (NOS) comprising 3 assessment items: selection, comparability, and outcomes. Studies that achieved six or more stars on the modified NOS were considered high quality.

Statistical analysis

To accurately analyze the statistical effect of various end point events, we calculated pooled odds ratio (OR) with a 95% confidence interval (CI) for dichotomous outcomes and the significance level was set to P < 0.05. The I [2] statistic (the significance level was set to P < 0.1) was used to assess the heterogeneity and determine the applicable effect model of each analysis. If I2 < 40%, the fixed-effect model was used, otherwise, the random-effect model was performed for the heterogeneity considered non-negligible. Stratified analyses were conducted according to different classification of age at admission (child, adult and mixed population). Egger’s test was performed to detect potential publication bias. All statistical analyses were conducted by Stata software 12.0.

Results

Characteristics of eligible studies

A total of 1,764 potential publications were identified from PubMed, Ovid, and Cochrane Library databases until January 1, 2023, in which 502 publications were determined as duplicates. Two investigators independently reviewed the remaining 1,262 publications by reading titles, abstracts, and full texts. Eventually, 11 observational studies with 12,212 participants were considered qualified for our meta-analysis, 5 of them only included adult population, 3 of them only included child population, and the other 3 studies included mixed population (adult plus child) [16, 25,26,27,28,29,30,31,32,33,34]. The flowchart of literature search was shown in Fig. 1.

The majority of included studies were conducted in U.S.A or China, except 1 in India and 1 in Italy. In all 12,212 patients, EEA and TCA were respectively performed in 6,910 (56.7%) and 5,268 (43.3%) patients. 55% of included patients were female. The time span of all included studies was between 2016 and 2021. Table 1 shows the characteristic of included studies.

It is accepted that the anatomical relationship, the consistency and the volume of the tumor may influence the surgeon’s choice of surgical approach, we described the radiological characteristic of the included studies (Table 2). Two among the 11 included studies fail to report these data [18, 31]. In the studies which reported these original data, there were no significantly statistical differences in the anatomical location, consistency, and volume of the tumor between the EEA and TCA groups. Table 3 and 4 showed the conclusive results of meta-analysis and advantage of two surgical approach, respectively.

Table 1 Characteristics of included studies
Table 2 Characteristics of radiological data of the two surgical groups
Table 3 The results of meta-analysis and stratified analysis in outcomes
Table 4 The significant advantages of a specific surgical approach

Quality of reporting assessment

Among 11 enrolled studies, 9 studies were identified high quality, whereas 2 studies were identified low quality. Overall NOS scores for quality assessment were shown in Fig. 2D.

Fig. 1
figure 1

Flow diagram for the selection of included articles

Fig. 2
figure 2

Results of Egger’s test and NOS scores: A) diabetes insipidus; B) death; C) infection; D) NOS scores of individual studies

Surgical outcomes

Gross total rection

Compared with TCA, the EEA achieved higher GTR rate in CPs patients (87.3% vs. 79.1%), notably, this superior effect was statistically significant (OR = 2.37, 95%CI: 1.17–4.81; I2 = 51.4%, p = 0.055, Fig. 3A). Nevertheless, stratified analysis demonstrated that there was no significant difference between the two approaches in adult (OR = 1.84, 95%CI: 0.41–8.16, p = 0.424; I2 = 54.9%, p = 0.106, Fig. 3A) and mixed (OR = 2.30, 95%CI: 0.89–6.10, p = 0.019; I2 = 63.3%, p = 0.066, Fig. 3A) populations, while the EEA showed statistically significant higher GTR rate in child population (OR = 5.25, 95%CI: 1.21–22.74, Fig. 3A).

Fig. 3
figure 3

Forest plot for surgical outcomes and endocrine functions: A) gross total resection; B) recurrence; C) visual deficit; D) visual improvement; E) diabetes insipidus; F) hypopituitarism

Recurrence

The EEA was positively correlated with the reduction of recurrence rate in a pooled analysis (OR = 0.44, 95%CI: 0.21–0.92, p = 0.030; I2 = 43.9%, p = 0.098, Fig. 3B), compared with TCA. The result of stratified analysis showed there were also statistically significant differences in child (OR = 0.15, 95%CI: 0.04–0.60, p = 0.007; I2 = 0%, Fig. 3B) and mixed (OR = 0.54, 95%CI: 0.31–0.94, p = 0.030; I2 = 0%, Fig. 3B) populations, nevertheless, this optimistic effect was not observed in adult population (OR = 0.41, 95%CI: 0.03–5.24, p = 0493; I2 = 68.6%, p = 0.041, Fig. 3B).

Visual deficit

Compared with TCA, EEA significantly reduced the postoperative incidence of new or worsened visual deficit (4.6% vs. 13.6%), and demonstrated a statistically significant difference in this surgical outcome in the pooled analysis with no detected heterogeneity (OR = 0.30, 95%CI: 0.26–0.34, p < 0.001; I2 = 0%, P = 0.547, Fig. 3C). Identically, stratified analysis supported this beneficial effect in adult (OR = 0.30, 95%CI: 0.26–0.35, p < 0.001; I2 = 14.3%, p = 0.321, Fig. 3C) and mixed (OR = 0.16, 95%CI: 0.04–0.58, p = 0.006; I2 = 0%, Fig. 3C) populations. However, there was no statistically significant difference in child (OR = 0.37, 95%CI: 0.02–8.14, p = 0.668, Fig. 3C) population.

Visual improvement

A percentage of 78.9% and 54.4% patients improved visual outcome after operation with EEA and TCA, respectively. Compared with TCA, the EEA statistically achieved greater likelihood of visual improvement with slight heterogeneity in a pooled analysis (OR = 2.59, 95%CI: 1.67-4.00, p < 0.001; I2 = 3.6%, p = 0.393, Fig. 3D). Notably, in stratified analysis, there were statistically significant difference between EEA and TCA in adult (OR = 3.42, 95%CI: 1.24–9.40, p = 0.017; I2 = 0%, Fig. 3D) and mixed populations (OR = 2.45, 95%CI:1.49–4.05, p < 0.001; I2 = 0%, Fig. 3D). No statistically significant difference was observed in child population (OR = 1.90, 95%CI:0.27–13.5, p = 0.522, Fig. 3D).

Endocrine functions

Diabetes insipidus

A total of 1,444 and 3,098 patients suffered from postoperative diabetes insipidus (DI), and the incidences of diabetes insipidus were 21.2% and 60.3% in patients underwent EEA and TCA, respectively. However, a pooled analysis indicated there was no statistically significant difference in preventing diabetes insipidus between EEA and TCA (OR = 0.47, 95%CI: 0.22–1.04, p = 0.063; I2 = 91.1%, P < 0.001, Fig. 3E). Similarly, no statistically significantly difference was observed in stratified analysis according to age classification (adult: OR = 0.45, 95%CI: 0.16–1.26, p = 0.128; child: OR = 0.23, 95%CI: 0.03–2.10, p = 0.193; mixed: 0.61, 95%CI: 0.27–1.38, p = 0.235, Fig. 3E).

Hypopituitarism

A total of 991 (14.3%) and 1,944 (37.2%) patients suffered from postoperative hypopituitarism in EEA and TCA groups, respectively. Compared with TCA, EEA showed statistically significantly lower incidence of hypopituitarism in pooled analysis (OR = 0.50, 95%CI: 0.28–0.88, p = 0.016; I2 = 76.8%, P < 0.001). Likewise, the statistically significant difference was also observed in child (OR = 0.34, 95%CI: 0.12–0.97, p = 0.043; I2 = 14.1, p = 0.312, Fig. 3F). However, subsequent stratified analysis presented opposite results in adult (OR = 0.40, 95%CI: 0.11–1.39, Fig. 3F) and mixed (OR = 0.72, 95%CI: 0.49–1.05, Fig. 3F) populations.

Complications

Cerebrospinal fluid leakage

The incidence of CSF leakage was 3.0% vs. 1.1% in EEA and TCA group, respectively. A pooled analysis indicated significantly higher CSF leakage rate in patients underwent EEA with mild heterogeneity, compared with TCA (OR = 2.80, 95%CI: 2.11–3.72, p < 0.001; I2 = 24.3%, p = 0.212, Fig. 4A). Similarly, stratified analysis showed EEA significantly enhanced the incidence of CSF leakage in all age groups (adult: OR = 2.33, 95%CI: 1.71–3.17; child: OR = 4.27, 95%CI: 1.65–11.1; mixed: OR = 18.18, 95%CI: 4.23–78.2, Fig. 4A).

Fig. 4
figure 4

Forest plot for postoperative complications. A) CSF leakage; B) death; C) stroke; D) infection; E) thrombosis; F) hydrocephalus

Death

The overall all caused death rate were respectively 0.5% and 4.7% in patients underwent EEA and TCA approach. Notably, adult population underwent EEA showed statistically significant difference in reducing death rate, compared with TCA (OR = 0.09, 95%CI: 0.06–0.15, p < 0.001; I2 = 1.6%, Fig. 4B). Nevertheless, there was no statistically significant difference between EEA and TCA in the pooled analysis (OR = 0.64, 95%CI: 0.16–2.54, p = 0.529, I2 = 66.5%, P = 0.002, Fig. 4B). Stratified analysis showed similar result in child (OR = 1.50, 95%CI: 0.23–9.73, p = 0.672, Fig. 4B) and mixed (OR = 1.02, 95%CI:0.28–3.70, p = 0.974, Fig. 4B) populations.

Postoperative stroke

Compared with TCA, the EEA presented a lower incidence (7.4% vs. 11.6%) of postoperative stroke (hemorrhagic or ischemic), and this beneficial effect was also statically significant with no detected heterogeneity in the pooled analysis (OR = 0.58, 95%CI: 0.51–0.66, p < 0.001, I2 = 0%, P = 0.942, Fig. 4C). Subsequent stratified analysis showed identical outcome in adult (OR = 0.58, 95%CI: 0.51–0.66, p < 0.001; I2 = 0%, p = 0.971, Fig. 4C). However, there were no statistically significant differences between EEA and TCA in child (OR = 0.39, 95%CI: 0.07–2.05, p = 0.246, Fig. 3C) and mixed (OR = 0.70, 95%CI: 0.27–1.84, p = 0.466, Fig. 4C) population.

Infection

A total of 78 and 180 patients (1.2% vs. 3.7%) suffered from postoperative infection in EEA and TCA group, respectively. Compared with TCA, EEA significantly reduced the incidence of postoperative infection with detected heterogeneity in pooled analysis (OR = 0.32, 95%CI: 0.24–0.42, P < 0.001; I2 = 0, Fig. 4D). On the contrary, stratified analysis did not support this beneficial effect in mixed population (OR = 0.52, 95%CI: 0.11–2.48, p = 0.407, Fig. 4D).

Thrombosis

The incidences of thrombosis (deep venous thrombosis or pulmonary embolism) in EEA and TCA group were respectively 0.8% and 4.9%. Compared with TCA, EEA showed statistically significant difference in preventing thrombosis a pooled analysis (OR = 0.24, 95%CI: 0.09–0.64, p = 0.004; I2 = 64.7%, P = 0.059, Fig. 3E). Stratified analysis showed statistically significant difference in child population (OR = 0.37, 95%CI: 0.15–0.93, P = 0.035, Fig. 3E), while the difference in child population was not statistically significant (OR = 0.25, 95%CI: 0.03–1.85, P = 0.175; I2 = 50.8%, p = 0.154, Fig. 4E).

Hydrocephalus

The lower incidence of hydrocephalus (2.0% vs. 24.3%) was observed in adults underwent EEA approach, compared with TCA. Nevertheless, this noticeable difference was not statistically significant with substantial heterogeneity in a pooled analysis (OR = 0.22, 95%CI: 0.02–2.97; I2 = 96.5%, P < 0.001, Fig. 4F). Stratified analysis showed significantly difference in adult (OR = 0.06, 95%CI: 0.05–0.07, p < 0.001, Fig. 4F) population, whereas the difference was not statistically significant in mixed population (OR = 0.68, 95%CI: 0.08–5.52, Fig. 4F).

Publication bias

The results of Egger’s test in the assessment of publication bias demonstrated three outcomes in the pooled analysis may carry a possibility of threat to the validity of meta-analysis, suggesting that the publication bias may affect the evidence-based decision making in recommendations of EEA and TCA in preventing postoperative diabetes insipidus, death and infection (Fig. 2A, B, C).

Discussion

Being one of the most challenging problems for neurosurgeons, CPs present an urgent requirement for neurosurgeons to provide high quality evidence for clinical practice and evidence-based decision-making for its management [2, 35]. Previous meta-analyses have reported only a pooled single-proportion and mostly included single series studies in their literature searches rather than comparative research, suggesting that the included studies in these meta-analyses may be clinically heterogeneous [13, 36]. Moreover, pooling single series research with different methodologies may present a potential source of bias for mismatching patients with different clinical characteristics, proficiency of operators, and originating from different countries, especially when comparing the pooled effect size between the EEA and TCA groups. Therefore, we performed a systematic review and meta-analysis by pooling the results of the comparative studies to provide more comprehensive and valid evidences on the clinical practice of CPs. This meta-analysis, which was based on 12,212 participants, is the largest comparative meta-analysis that focused on the safety and effect of the EEA and TCA in the management of CPs. To minimize the clinical heterogeneity, we only included observational studies that directly compared the effects and safety of the EEA and TCA for treating CPs. Notably, in consideration of the different age populations being the main source of clinical heterogeneity, which may affect the reliability of the evidence, we performed a stratified analysis to limit the potential influence of bias caused by ages.

Previous studies have suggested that the GTR is associated with a significantly lower recurrence rate compared with STR, resulting in the achievement of GTR being generally accepted as the primary objective for surgical management in CP patients [4, 5, 10, 37]. Controversially, studies investigating whether GTR differs from STR + RT (subtotal resection plus adjuvant radiation therapy) have reported comparable long-term survival rates and postoperative complications [37, 38]. However, despite the limited choice of patients to select a specific medical center that offers the radiation therapy service, feasibility of the selected patients whose tumor could easily achieve GTR, and undetermined potential iatrogenic injury by radiation therapy, especially in children, GTR should still be recommended as the main goal for neurosurgeons when resecting CP tumors [2, 13, 37, 39]. In this study, the aggregated data from existing publications showed a significant association between the EEA and a higher GTR rate in a pooled analysis compared with TCA (OR = 2.37, 95%CI 1.17–4.81, p = 0.017). This superior effect is consistent with previous meta-analyses and supports the fact that EEA can provide a clear and broad field of vision, confirm the relationship between the pituitary stalk and tumor, protect the superior pituitary artery, and prevent the destruction of brain tissue via microsurgical methods.

Although the pooled effect supports the recommendation of EEA in patients with CP for attaining a higher GTR rate and is consistent with a previous meta-analysis published in 2011, the results of the stratified analysis could provide more individualized evidence for clinical practice [13]. In the stratified analysis, the EEA did not show any significant difference in the adult (OR = 1.84, 95% CI 0.41–8.16, p = 0.424) and mixed (OR = 2.45, 95% CI 0.87–6.87, p = 0.066) groups for achieving a higher GTR rate as compared with TCA. Generally, although a higher GTR rate was commonly considered as an advantage of the EEA by most published researchers, the results from our study and those of several recent studies did not support this superiority, suggesting that the possibility of the surgical technique of the TCA in neurosurgeons might have improved along with the development of other surgical techniques [11, 40]. Moreover, Younus et al. confirmed that the higher GTR rate was significantly achieved by senior specialists than surgeons with limited clinical practice (71% vs. 47%, p < 0.05), suggesting that the GTR rate in EEA might increase as neurosurgeons improve their surgical process using the EEA in the next decade [41]. Contrary to the adult group, the child group exhibited a significantly higher GTR rate in the EEA group (OR = 5.25, 95% CI 1.21–22.7, p = 0.027). However, only one study was included in calculating the effect size. A current research identified the safety of the EEA in pediatric patients, eliminating the concerns of several pioneers regarding the potential influence of the EEA affecting the midfacial development of children. Our result is similar to that of a previous meta-analysis, which reported a notably high-pooled GTR proportion (75.8%) in pediatric patients under the EEA, suggesting that the recommendation of the EEA in children should be positive. Moreover, although a few studies identified significantly different incidences of complications between the earlier and latter groups, published series in this field did not sufficiently report the difference between the earlier and latter cohorts [41, 42]. Therefore, although the EEA has been considered the first-line treatment option, evidence of the association between the EEA and GTR rate among adults is limited, and further research is needed to identify long-term outcomes. In conclusion, given these considerations, the formulation of the surgical strategy should follow the guidance of the preoperative assessment, which must include the clinical characteristics, such as tumor texture, magnetic resonance imaging (MRI) findings, presenting symptoms, and endocrine function.

Pioneers have confirmed that the higher achievement of GTR is commonly accompanied by a significantly lower recurrence rate in primary CP resection [9, 43]. In our study, although EEA showed a significant reduction in recurrence, as previously mentioned, the EEA achieved a higher GTR rate in the pooled analysis. These results strongly support the recommendation of the EEA based on its superiority in GTR and avoiding recurrence in primary CP resection. However, unlike the findings of a previous meta-analysis, the stratified analysis in this study significantly supported the superiority of the EEA in the child population (OR = 0.15, p = 0.007) [8, 12]. Notably, contrary to our study (OR = 1.84, p = 0.424), a previous meta-analysis reported a significant superiority of the EEA in GTR in the adult population [44]. These controversial results might be attributed to the fact that the previous meta-analysis only enrolled one single series rather than comparative series and the STR + RT was recently accepted as an equivalent treatment with a similar recurrence rate as compared with achieving GTR [38, 45].

With the revolutionized application of the nasoseptal flap in skull base reconstruction, the CSF leakage rate is significantly reduced in endoscopic skull base surgery as compared with the traditional flap [46]. In our study, the EEA showed a significant association with CSF leakage in a pooled analysis (OR = 2.80, 95% CI 2.11–3.72, p < 0.001) and stratified analysis (adult, OR = 2.33, 95%CI 1.71–3.17; child, OR = 4.27, 95% CI 1.65–11.1; mixed, OR = 18.18, 95% CI 4.23–78.2). Optimistically, the pooled 3.0% incidence of the postoperative CSF leakage is generally acceptable, considering the EEA showed a significant reduction in the postoperative infection rate (overall, 0.32, p < 0.001; adult 0.31, p < 0.001). On the other hand, a recent prospective, randomized controlled trial determined that the placement of perioperative lumbar drainage could significantly decrease the incidence of postoperative CSF leakage as compared with the control group (OR = 3.0, 95% CI 1.2–7.6, p = 0.017) [47]. Furthermore, this study might change the clinical practice guidelines of the perioperative management of endoscopic skull base surgery, providing more data to future research.

The visual outcome is commonly accepted as the focus of neurosurgeons when it comes to assessing the operation results and quality of life. In this study, the pooled analysis identified the significant advantage of the EEA not only in improving visual outcomes but also in preventing visual deficits, especially in adults (only one study involving a child population was enrolled). These results were consistent with those of previous meta-analyses. Moreover, a meta-analysis on a mixed population conducted by Ricardo et al. showed similar results, suggesting the potential advantage of the EEA in children [13, 44, 48]. Recently, Qiao et al. have determined two independent risk factors (i.e., tight adhesion and larger tumor volume) for postoperative visual field defects and confirmed that the use of intraoperative visual evoked potential (VEP) reliably guided neurosurgeons to minimize intraoperative injury of the optic chiasma and prevent postoperative visual deterioration in the adult population [3]. Therefore, despite the uncertainty of the surgical effect of the EEA in children, the EEA procedure plus intraoperative VEP monitoring could be strongly recommended as the preferred option when formulating an individualized surgical strategy for adult patients with presenting symptoms of visual deficits or compressed optic nerve.

Generally, the EEA presents a more direct visualization of the pituitary stalk and minimizes the need for cerebral retraction and the manipulation of neurovascular structures, providing a theoretical and clinical reduction in postoperative endocrine results (diabetes insipidus and hypopituitarism). Nevertheless, in this study, unlike previous meta-analyses, no significant differences in diabetes insipidus and hypopituitarism were observed between the EEA and TCA in both the child and adult populations, except that the EEA significantly decreased postoperative hypopituitarism in the child population (OR = 0.34, p = 0.043)8,11,48. These controversial results might be attributed to the detected publication bias (p = 0.046), various classifications of endocrine dysfunction (hypothyroidism, hypogonadism, adrenal insufficiency, and growth hormone deficiency), different growth directions of the CPs, and the definition of DI duration (temporary or permanent). Fan et al. assessed the different surgical and endocrine outcomes of the EEA and TCA in CP resection in adults and identified the contrary results of postoperative hypopituitarism between the T-CP (TCA preceded EEA, p = 0.016) and Q-CP (EEA preceded TCA, p = 0.008) patients, respectively [30]. Given these considerations, it can be suggested that future original studies, especially prospective studies, should formulate a comprehensive statistical scheme, which could increase reliability and precision for clinical guidelines and evidence-based decision-making.

The stratified analysis of the complications in our study showed that, for adults, the EEA reduced the postoperative infection, stroke, hydrocephalus, and all-cause death rate. However, for pediatric patients, the EEA only decreased postoperative thrombosis. These superiorities of the EEA might be attributed to its advance in the surgical field, minor injuries to the brain tissue, and shorter LOS. Notably, the higher CSF leakage rate in the EEA group in all populations, as previously mentioned, did not sufficiently cause a higher infection and death rate, suggesting that this complication should not be a main concern when surgeons were about to determine the individualized surgical approach.

Additionally, original studies in this research field occasionally reported incomparable outcomes. For example, several studies have proven the median of LOS, while others preferred the mean number or interquartile range. However, the absence of accurate definitions of clinical outcomes, such as hypopituitarism and DI in original studies, may lead to less precise results. Therefore, the lack of report of detailed outcomes limited our study to provide sufficient evidence and further analysis. More importantly, the absence of radiologically characteristic of CP may lead a potential incomparability between two different interventions. Therefore, we recommend that further study should accurately report the relevant data to improve the quality of evidence in this field. Furthermore, we were unable to sufficiently compare the association of the surgical approach and tumor volumes, various QST classifications, and specific tumor texture. Thus, future research is needed to investigate these clinical heterogeneities.

Conclusions

The advance and prevalence of EEA significantly improved several postoperative surgical outcomes, endocrine functions, and complications in primary CP resection as compared with the traditional TCA. For adults, the EEA showed significant superiority in decreasing postoperative hydrocephalus, stroke, infection, mortality, and visual deficit. Moreover, for pediatric patients, the EEA was associated with a significantly higher GTR rate, less recurrences, and lower hypopituitarism rate. The only significant disadvantage of the EEA was the higher CSF leakage rate. Nevertheless, despite the higher CSF leakage rate, the EEA unexpectedly showed a significantly lower rate of postoperative infection, suggesting that this inferior effect could not be considered as a main concern when surgeons were determining the EEA as the optimal approach for primary CP resection.

Data availability

No datasets were generated or analysed during the current study.

References

  1. Momin AA, Recinos MA, Cioffi G, et al. Descriptive Epidemiol Craniopharyngiomas United States. 2021;24(4):517–22.

    CAS  Google Scholar 

  2. Müller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S. Craniopharyngioma. Nat Reviews Disease Primers. 2019;5(1):75.

    Article  PubMed  Google Scholar 

  3. Qiao N, Yang X, Li C et al. The predictive value of intraoperative visual evoked potential for visual outcome after extended endoscopic endonasal surgery for adult craniopharyngioma. J Neurosurg 2021:1–11.

  4. Mende KC, Kellner T, Petersenn S et al. Clinical Situation, Therapy, and Follow-Up of adult Craniopharyngioma. J Clin Endocrinol Metab 2020;105(1).

  5. Bal E, Öge K, Berker M. Endoscopic endonasal transsphenoidal surgery, a Reliable Method for treating primary and Recurrent/Residual craniopharyngiomas: nine years of experience. World Neurosurg. 2016;94:375–85.

    Article  PubMed  Google Scholar 

  6. Komotar RJ, Starke RM, Raper DM, Anand VK, Schwartz TH. Endoscopic skull base surgery: a comprehensive comparison with open transcranial approaches. Br J Neurosurg. 2012;26(5):637–48.

    Article  PubMed  Google Scholar 

  7. Cavallo LM, Frank G, Cappabianca P, et al. The endoscopic endonasal approach for the management of craniopharyngiomas: a series of 103 patients. J Neurosurg. 2014;121(1):100–13.

    Article  PubMed  Google Scholar 

  8. Qiao N. Endocrine outcomes of endoscopic versus transcranial resection of craniopharyngiomas: a system review and meta-analysis. Clin Neurol Neurosurg. 2018;169:107–15.

    Article  PubMed  Google Scholar 

  9. Rock AK, Dincer A, Carr MT, Opalak CF, Workman KG, Broaddus WC. Outcomes after craniotomy for resection of craniopharyngiomas in adults: analysis of the National Surgical Quality Improvement Program (NSQIP). J Neurooncol. 2019;144(1):117–25.

    Article  PubMed  Google Scholar 

  10. Chen W, Gardner PA, Branstetter BF, et al. Long-term impact of pediatric endoscopic endonasal skull base surgery on midface growth. J Neurosurg Pediatr. 2019;23(4):523–30.

    Article  PubMed  Google Scholar 

  11. Webb KL, Pruter WW, Hinkle ML, Walsh MT. Comparing Surgical approaches for Craniopharyngioma Resection among adults and children: a Meta-analysis and systematic review. World neurosurgery.; 2023.

  12. Pang JC, Chung DD, Wang J, Abiri A. Characteristics and outcomes in Pediatric Versus Adult Craniopharyngiomas: a systematic review and Meta-analysis. 2023;92(6):1112–29.

  13. Elliott RE, Jane JA Jr., Wisoff JH. Surgical management of craniopharyngiomas in children: meta-analysis and comparison of transcranial and transsphenoidal approaches. Neurosurgery. 2011;69(3):630–43. discussion 643.

    Article  PubMed  Google Scholar 

  14. Na MK, Jang B, Choi KS, et al. Craniopharyngioma resection by endoscopic endonasal approach versus transcranial approach: a systematic review and meta-analysis of comparative studies. Front Oncol. 2022;12:1058329.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Figueredo LF, Martínez AL, Suarez-Meade P et al. Current role of Endoscopic Endonasal Approach for Craniopharyngiomas: a 10-Year systematic review and Meta-analysis comparison with the Open Transcranial Approach. Brain Sci 2023;13(6).

  16. Li X, Wu W, Miao Q, et al. Endocrine and metabolic outcomes after transcranial and endoscopic endonasal approaches for primary resection of Craniopharyngiomas. World Neurosurg. 2019;121:e8–14.

    Article  PubMed  Google Scholar 

  17. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Commun Health. 2013;67(11):974–8.

    Article  Google Scholar 

  18. Lin L, Xu C. Arcsine-based transformations for meta-analysis of proportions: pros, cons, and alternatives. Health Sci Rep. 2020;3(3):e178.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Borges Migliavaca C, Stein C, Colpani V, Barker TH, Munn Z, Falavigna M. How are systematic reviews of prevalence conducted? A methodological study. BMC Med Res Methodol. 2020;20(1):96.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Aabedi AA, Young JS, Phelps RRL, Winkler EA, McDermott MW, Theodosopoulos PV. Comparison of outcomes following primary and repeat resection of Craniopharyngioma. J Neurol Surg Part B Skull base. 2022;83(Suppl 2):e545–54.

    Google Scholar 

  21. Elliott RE, Hsieh K, Hochm T, Belitskaya-Levy I, Wisoff J, Wisoff JH. Efficacy and safety of radical resection of primary and recurrent craniopharyngiomas in 86 children. J Neurosurg Pediatr. 2010;5(1):30–48.

    Article  PubMed  Google Scholar 

  22. Müller HL, Craniopharyngioma. Endocr Rev. 2014;35(3):513–43.

    Article  PubMed  Google Scholar 

  23. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg (London England). 2021;88:105906.

    Article  Google Scholar 

  24. Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ (Clinical Res ed). 2017;358:j4008.

    Article  Google Scholar 

  25. Gallotti AL, Barzaghi LR, Albano L, et al. Comparison between extended transsphenoidal and transcranial surgery for craniopharyngioma: focus on hypothalamic function and obesity. Pituitary. 2022;25(1):74–84.

    Article  PubMed  Google Scholar 

  26. Ozgural O, Kahilogullari G, Dogan I, et al. Single-Center Surgical experience of the treatment of Craniopharyngiomas with emphasis on the Operative Approach: endoscopic endonasal and open microscopic transcranial approaches. J Craniofac Surg. 2018;29(6):e572–8.

    Article  PubMed  Google Scholar 

  27. Moussazadeh N, Prabhu V, Bander ED, et al. Endoscopic endonasal versus open transcranial resection of craniopharyngiomas: a case-matched single-institution analysis. NeuroSurg Focus. 2016;41(6):E7.

    Article  PubMed  Google Scholar 

  28. Wannemuehler TJ, Rubel KE, Hendricks BK, et al. Outcomes in transcranial microsurgery versus extended endoscopic endonasal approach for primary resection of adult craniopharyngiomas. NeuroSurg Focus. 2016;41(6):E6.

    Article  PubMed  Google Scholar 

  29. Konar SK, Kulkarni AV, Shukla D. Management options for Suprasellar Cystic Craniopharyngioma. Endoscopic Transventricular Approach Microsurgical Approach. 2021;12(2):343–9.

    Google Scholar 

  30. Fan J, Liu Y, Pan J et al. Endoscopic endonasal versus transcranial surgery for primary resection of craniopharyngiomas based on a new QST classification system: a comparative series of 315 patients. J Neurosurg 2021:1–12.

  31. Govindarajan V, Luther EM, Morell AA, et al. Perioperative complications in Endoscopic Endonasal versus Transcranial resections of Adult Craniopharyngiomas. World Neurosurg. 2021;152:e729–37.

    Article  PubMed  Google Scholar 

  32. Madsen PJ, Buch VP, Douglas JE et al. Endoscopic endonasal resection versus open surgery for pediatric craniopharyngioma: comparison of outcomes and complications. J Neurosurg Pediatr 2019:1–10.

  33. Parasher AK, Lerner DK. The impact of expanded endonasal skull base surgery on midfacial growth in pediatric patients. 2020;130(2):338–42.

  34. Nie C, Ye Y, Wu J, Zhao H, Jiang X, Wang H. Clinical outcomes of transcranial and endoscopic endonasal surgery for Craniopharyngiomas: a single-Institution experience. Front Oncol. 2022;12:755342.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Pereira AM, Schmid EM, Schutte PJ, et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol. 2005;62(2):197–204.

    Article  Google Scholar 

  36. Lee JA, Cooper RL, Nguyen SA, Schlosser RJ, Gudis DA. Endonasal endoscopic surgery for Pediatric Sellar and Suprasellar lesions: a systematic review and Meta-analysis. Otolaryngology–head neck Surgery: Official J Am Acad Otolaryngology-Head Neck Surg. 2020;163(2):284–92.

    Article  Google Scholar 

  37. Grewal MR, Spielman DB. Gross total Versus Subtotal Surgical Resection in the management of Craniopharyngiomas. 2020;11:2152656720964158.

  38. Wang G, Zhang X, Feng M, Guo F. Comparing survival outcomes of gross total resection and subtotal resection with radiotherapy for craniopharyngioma: a meta-analysis. J Surg Res. 2018;226:131–9.

    Article  PubMed  Google Scholar 

  39. Henderson F Jr., Schwartz TH. Update Manage Craniopharyngiomas. 2022;156(1):97–108.

    Google Scholar 

  40. Cagnazzo F, Zoli M, Mazzatenta D, Gompel JJV. Endoscopic and microscopic transsphenoidal surgery of Craniopharyngiomas: a systematic review of Surgical outcomes over two decades. J Neurol Surg Part Cent Eur Neurosurg. 2018;79(3):247–56.

    Article  Google Scholar 

  41. Younus I, Gerges MM, Uribe-Cardenas R, et al. How long is the tail end of the learning curve? Results from 1000 consecutive endoscopic endonasal skull base cases following the initial 200 cases. J Neurosurg. 2020;134(3):750–60.

    Article  PubMed  Google Scholar 

  42. Koutourousiou M, Gardner PA, Tormenti MJ, et al. Endoscopic endonasal approach for resection of cranial base chordomas: outcomes and learning curve. Neurosurgery. 2012;71(3):614–24. discussion 624 – 615.

    Article  PubMed  Google Scholar 

  43. Xu D, Wei Q, Li Z, et al. Development and Validation of Predicting Nomograms for Craniopharyngioma: a retrospective, Multiple-Center, Cohort Study. Front Oncol. 2021;11:691288.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Komotar RJ, Starke RM, Raper DM, Anand VK, Schwartz TH. Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of craniopharyngiomas. World Neurosurg. 2012;77(2):329–41.

    Article  PubMed  Google Scholar 

  45. Dandurand C, Sepehry AA, Asadi Lari MH, Akagami R, Gooderham P. Adult craniopharyngioma: Case Series, systematic review, and Meta-Analysis. Neurosurgery. 2018;83(4):631–41.

    Article  PubMed  Google Scholar 

  46. Cai X, Yang J, Zhu J, et al. Reconstruction strategies for intraoperative CSF leak in endoscopic endonasal skull base surgery: systematic review and meta-analysis. Br J Neurosurg. 2022;36(4):436–46.

    Article  PubMed  Google Scholar 

  47. Jonathan GE, Sarkar S, Singh G, Mani S, Thomas R, Chacko AG. A randomized controlled trial to determine the role of intraoperative lumbar cerebrospinal fluid drainage in patients undergoing endoscopic transsphenoidal surgery for pituitary adenomas. Neurol India. 2018;66(1):133–8.

    Article  PubMed  Google Scholar 

  48. Akinduro OO, Izzo A, Lu VM, et al. Endocrine and visual outcomes following gross total resection and Subtotal Resection of Adult Craniopharyngioma: systematic review and Meta-analysis. World Neurosurg. 2019;127:e656–68.

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by the Natural Science Foundation of Hubei Province [grant number 2021CFB549].

Author information

Authors and Affiliations

Authors

Contributions

HJ.W, FC.Z, and XB.J conceived and designed this study. S.L and YF.Y selected the articles and extracted the data. S.L, YF.Y, KX.Y and CS.N analyzed the data. S.L and X.H wrote the first and revised draft of the manuscript. ZD.H, CZ and YM.N contributed to the writing of the final version of the manuscript. All authors reviewed and approved the final version of this manuscript.

Corresponding authors

Correspondence to Fangcheng Zhang, Xiaobing Jiang or Haijun Wang.

Ethics declarations

Ethics approval and consent to participate

Ethical approval was not applicable because this meta-analysis was based on published literature.

Provenance and peer review

Not commissioned, externally peer-reviewed.

Human Ethics

Not applicable.

Consent to participate

Not applicable.

Competing interest

The authors declare that there are no perceived conflicts of interest in this work.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, S., Ye, Y., Nie, C. et al. Endoscopic endonasal transsphenoidal approach improves endocrine function and surgical outcome in primary craniopharyngioma resection: a systematic review and meta-analysis. World J Surg Onc 22, 137 (2024). https://doi.org/10.1186/s12957-024-03411-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12957-024-03411-8

Keywords